Can Wegovy Cause Lightheadedness or Dizziness?

What actually causes the dizzy spells?

A question our prescribers hear most weeks is whether lightheadedness on Wegovy is the drug itself or something the drug is causing indirectly. Usually, it is the latter. Semaglutide slows gastric emptying and suppresses appetite strongly, especially in the early weeks. If nausea or vomiting means you are eating and drinking less than usual, mild dehydration follows quickly, and dehydration is one of the most reliable triggers for that unsteady, head-swimming feeling.

There is also a direct mechanism: semaglutide can modestly lower blood pressure. For most people that is a welcome side effect, but it can tip into symptomatic low blood pressure, particularly when standing up quickly. The technical term is orthostatic hypotension, and it tends to be worse on an empty stomach or after time in a warm room. The semaglutide overview on this site covers the broader pharmacological picture if you want more background.

A third factor is calorie restriction itself. When food intake drops sharply (as it often does in the first month) blood-sugar swings can occur even in people without diabetes, producing lightheadedness after meals or between them. None of these causes is dangerous on its own, but they are worth distinguishing because the fix differs for each one.

Who tends to notice it most, and when?

Timing follows a predictable pattern. Lightheadedness peaks in the first four weeks of a new dose, which is why the titration schedule builds gradually, the body tolerates a smaller dose while it adapts. The NHS notes dizziness among the known side effects of semaglutide on its medicines pages, alongside the wider GI-led side-effect profile.

People most likely to feel it markedly are those who already have lower blood pressure, those on antihypertensives or diuretics, anyone with a tendency toward dehydration, and people who are eating very little during the first titration period. Age is a factor too: older adults often have less vascular elasticity to compensate for rapid postural changes. If you take blood-pressure medicines, your prescriber should know, the combination may need monitoring, particularly at dose increases.

The good news is that, for the majority, dizziness is mild and short-lived. In the STEP 1 trial of 2.4mg semaglutide, the side-effect profile that led to discontinuation was dominated by GI symptoms, not dizziness, suggesting most participants found the lightheadedness manageable. You can read the full STEP 1 data in the published NEJM paper.

Practical steps that can reduce it

Small, consistent habits make a real difference here. Drink water steadily across the day rather than in large amounts at once, sipping is better when nausea is present. Rise from chairs and bed slowly, giving your circulation a second to catch up. Eating small amounts of protein at regular intervals, even if appetite is suppressed, helps steady blood-sugar levels and reduces the post-meal dip that can produce lightheadedness.

Alcohol deserves a mention. It has its own vasodilatory and dehydrating effects, and combining it with Wegovy can amplify dizziness noticeably. The Wegovy and alcohol page covers this in more detail. Caffeine in large quantities can also play a role if it is worsening dehydration.

If lightheadedness is disrupting daily life, that is worth reporting to your prescriber before the next scheduled check-in, not after it. Dose-slowing or a temporary pause is sometimes the right call. Treatment costs and options are covered on the Wegovy cost page if you are weighing up the overall picture.

When lightheadedness is a warning sign, not a passing nuisance

Most of the time, lightheadedness on Wegovy is transient and has a straightforward explanation. But some presentations warrant same-day medical attention rather than reassurance. Seek help promptly if dizziness is severe or sudden in onset, if you faint or come close to fainting, if it accompanies chest pain or palpitations, or if it arrives alongside severe, persistent stomach pain that radiates to the back, the last combination can indicate pancreatitis, which the MHRA flagged in a Yellow Card safety update as an infrequent but serious risk with GLP-1 medicines.

Likewise, if you are also experiencing symptoms that make you wonder about other side effects, the Wegovy side effects overview or the page on Wegovy and digestive symptoms may answer related questions. Suspected adverse reactions can be reported through the Yellow Card scheme at yellowcard.mhra.gov.uk, it helps the MHRA build a clearer picture of how these medicines behave in real-world use. If you are considering starting treatment and want a prescriber to review your individual circumstances, check your eligibility through a free consultation with the nume clinical team.